Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis. Oncotarget. 2015; 6:27700-27713.

2016年01月07日 00:00 点击：[]

Wang JX#, Feng C#, He YQ#，Ding W, Sheng JQ, Arshad M, Zhang XJ, Li PF*. Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.Oncotarget. 2015 6(29):27700-27713.

上一条：TBK1 inhibitors: a review of patent literature (2011 - 2014). Expert Opin Ther Pat. 2015;21:1-12. 下一条：Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus. Appl Microbiol Biotechnol. 2015 Oct 3

【关闭】